OKUR
OnKure Therapeutics, Inc.
+0.08 (+2.78%)2.96USD38.8K成交股數120M市值–本益比(近四季)34.9股價營收比+66.3%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 1.6M+66% | 458K-57% | – | 802K-1923% | 934K+358% | 1.1M+264% | – | −44K | 204K | 295K | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 12.6M | 11.7M | – | 11.9M | 12.6M | 13.0M | – | 10.1M | 10.8M | 8.6M | 13.6M | 14.4M |
| 銷售管理費用 | 4.3M | 3.9M | – | 3.6M | 3.7M | 4.0M | – | 1.4M | 3.6M | 1.3M | 7.3M | 6.6M |
| 營業利益 | −16.9M+4% | −15.6M-8% | – | −15.5M+35% | −16.3M+14% | −17.0M+73% | – | −11.5M-45% | −14.3M | −9.8M | −20.9M | −21.0M |
| 營業利益率 | -1,088.2% | -3,409.4% | – | -1,932.8% | -1,747.8% | -1,581.4% | – | 26,163.6% | -7,030.9% | -3,332.5% | – | – |
| 稅後淨利 | −15.3M-0% | −15.2M-5% | −13.5M-23% | −14.7M+27% | −15.4M+9% | −15.9M+67% | −17.4M-9% | −11.6M-41% | −14.1M | −9.5M | −19.2M | −19.5M |
| 淨利率 | -988.2% | -3,309.4% | – | -1,832.8% | -1,647.8% | -1,481.4% | – | 26,263.6% | -6,930.9% | -3,232.5% | – | – |
| 稀釋 EPS | -0.31-73% | -1.11-7% | – | -1.09-97% | -1.14-97% | -1.19-96% | – | -36.55+5523% | -44.82 | -30.37 | -5.68 | -0.65 |
| 稀釋股數 | 49.9M | 13.7M | – | 13.5M | 13.5M | 13.4M | – | 316K | 315K | 314K | 3.4M | 30.2M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 167M | 192M | 59.1M | 70.3M | 83.4M | 96.7M | 111M | 60.7M | 36.0M | 20.4M | 11.7M | 9.1M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 179M | 199M | 62.1M | 72.8M | 86.1M | 99.9M | 115M | 77.6M | 78.7M | 84.6M | 130M | 148M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 7.2M | 14.3M | 5.9M | 6.4M | 7.9M | 9.2M | 11.1M | 3.6M | 1.8M | 3.4M | 15.4M | 15.5M |
| 股東權益 | 172M | 184M | 56.2M | 66.4M | 78.2M | 90.6M | 104M | −135M | −124M | −111M | 115M | 133M |
| 負債比 | 4.0% | 7.2% | 9.6% | 8.8% | 9.2% | 9.2% | 9.6% | 4.7% | 2.3% | 4.0% | 11.8% | 10.5% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −12.9M-8% | – | – | – | −14.0M+32% | – | – | – | −10.6M | – | – |
| 資本支出 | – | 5K | – | – | – | 18K | – | – | – | 9K | – | – |
| 自由現金流 | – | −12.9M-8% | – | – | – | −14.0M+32% | – | – | – | −10.6M | – | – |
| 折舊攤銷 | – | 104K | – | 108K | 117K | 118K | – | 114K | 115K | 114K | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -2,826.0% | – | – | – | -1,304.5% | – | – | – | -3,606.1% | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 3.4M | – | −59.5M | -1,733.7% | -4.40 | −51.9M |
| FY2024 | 0.00 | -100.0% | −52.7M | –% | -15.28 | −51.2M |
| FY2023 | 1.6M | – | −35.3M | -2,175.7% | -124.41 | −34.8M |
| FY2022 | – | – | −52.0M | –% | -2.12 | −47.7M |
| FY2021 | – | – | −39.8M | –% | -2.19 | −38.2M |
| FY2020 | – | – | −19.5M | –% | -9.60 | −18.6M |